Berkshire Hathaway reported a 17.7% increase in operating earnings for Q1 year-over-year, driven by a focused equity portfolio and strategic cash management under Abel's leadership. However, growth is limited by cash drag and rotation in the equity book, with modest share buybacks and ongoing uncertainty around Warren Buffett's estate impacting the company's valuation multiple. The firm has increased exposure to Japan but has not made any major transformative investments. The analyst maintains a Hold rating with a $519 per share target, noting limited upside of 6.8% and that Berkshire is unlikely to outperform the S&P 500 in the near term.
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...
New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...
BlackRock reported quarterly earnings per share of $13.91, surpassing analyst estimates of $12.69, and revenue of $7.08 billion, exceeding expectations of $6.73 billion. The company’s assets under management reached a record $15.3 trillion, a 22% inc...
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
